Preview

Military Medicine

Advanced search

Peculiarities of hemostasisin newborns from mothers with new coronavirus infection SARS-CoV-2 (COVID-19)

https://doi.org/10.51922/2074-5044.2022.2.39

Abstract

Information about the health status of newborns from mothers infected with the SARS-CoV-2 coronavirus is few and contradictory, and there is practically no information on hemocoagulation disorders in such children in the available literature. Meanwhile, hemostasis disorders are one of the most urgent problems in neonatology. The importance of the stated topic is due to the potential risk of developing life-threatening conditions due to possible violations of the functions of vital organs, severe hypoxia resulting from massive blood loss. The aim of our study was to study the features of hemocoagulation disorders in newborns from mothers with coronavirus infection caused by SARS-CoV-2 (COVID-19). Confirmation of COVID-19 infection was a positive PCR test – detection of SARS-CoV-2 coronavirus RNA detected in women during pregnancy (in the second trimester or immediately before childbirth). Clinical, laboratory, and biochemical research methods were used in the examination of children. It was revealed that a transmitted coronavirus infection in the second half of pregnancy and before childbirth, indirectly affecting the fetus through the uteroplacental blood flow, exacerbates microcirculatory disorders, which leads to more pronounced hemorrhagic disorders in the newborn

About the Authors

I. А. Loginova
УО «Белорусский государственный медицинский университет»
Belarus


E. N. Alferovich
УО «Белорусский государственный медицинский университет»
Belarus


E. Kordzakhia
УЗ «5-я городская клиническая больница»
Belarus


I. N. Sorokovik
УЗ «5-я городская клиническая больница»
Belarus


I. N. Seredich
УЗ «5-я городская клиническая больница»
Belarus


References

1. World Health Organization (WHO) Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019

2. Mascio D., Asma K. Saccone G. Outcome of Coronavirus spectrum infections (SARS. MERS. COVID 1-19) during pregnancy:a systematic review and meta-analysis. Am J Obstet Gynecol 2020. https://doi.org/10.1016/j.ajogmf.2020.100107

3. World Health Organization (WHO) Q&A on COVID-19. pregnancy. childbirth and breastfeeding. https://www.who.int/news-room/q-a-detail/q-a-on-covid-19-pregnancychildbirth-and-breastfeeding

4. COVID-19 and Breastfeeding Position Paper. European Paediatric Association. the Union of National European Paediatric Societies and Associations (EPA/UNEPSA). https://r.epa-unepsa.eu/i/sSSE9qOATiQSgn-7s12OA1kqh62ccuew

5. Chen H., Guo J. Wang C et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395 (10226): 809–15.

6. Viser J. Thromboprophylakhis for recurrent miscarriage in women with or without thrombophilia. HABENOkh: a randomized multicenter trial. Thromb Haemost 2011; 105(2): 295-301.

7. Zeng L., Xia S. Yuan W et al. Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan. China. JAMA Pediatrics Published online March 26. 2020. DOI: 10.1001/jamapediatrics.2020.0878

8. Zhu H., Wang L. Fang C et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV. Transl Pediatr 2020; 9 (1): 51–60. http://dx.doi.org/10.21037/tp.2020.02.06

9. Zhukovskaya S. Beremennost i COVID-19 – rezultaty poslednikh nauchnykh issledovaniy. Belta.by/interview/view/beremennost-covid-19-resultaty-poslednih-nauchnih-isledovaniy-7636.

10. Zaplatnikov A. L., V. V. Gorev, A. V. Dmitriyev, A. A. Dementyev, Zh. L. Chabaidze, V. I. Svinitskaya. Pediatricheskiye voprosy o novoy koronavirusnoy infektsii – est li na nikh segodnya otvety / A. L. Zaplatnikov // Pediatriya. Consilium Medicum 2020; 1: 16-19.

11. Murashko. A. V. Antikoagulyantnaya teraрiya pri beremennosti / A. V. Murashko // Trudnyy patsiyent. – 2009. – № 1. – S. 21–27.

12. Nekotoryye aspekty kliniko-laboratornykh pokazateley u novorozhdennykh ot materey s koronavirusnoy infektsiyey. vyzvannoy SARS-CoV-2 (COVID19). infitsirovannykh v razlichnyye sroki perinatalnogo perioda // I. A. Loginova [i dr.] // Neotlozhnaya kardiologiya i kardiovaskulyarnyye riski. – 2021. – T. 5. – № 1. – S. 1205–1212.

13. Sindrom dezadaptatsii serdechno-sosudistoy sistemy u novorozhdennykh detey. rodivshikhsya ot materey s novoy koronavirusnoy infektsiyey. vyzvannoy SARS-CoV-2 // E. N. Alferovich, I. A. Loginova, I. N. Seredich, E. N. Sarzhevskaya. – 2022. – № 1. – S. 14–19.

14. Prediktory gemorragicheskoy bolezni novorozhdennykh: sovremennyye aspekty izvestnoy problem // I. A. Loginova, K. V. Kovaleva, I. V. Lakizo, A. V. Sushchevskiy. – 2018. – № 3. – S. 94–99

15. Shabalov N. P. Neonatologiya: v 2-kh t. T 2.: uchebnoye posobiye// N. P. Shabalov i dr. – 7-u izd., pererab. i dop. – Moskva: GEOTAR-Media. 2020. – 752 s. – ISBN 978-5-9704-5771-9.


Review

For citations:


Loginova I.А., Alferovich E.N., Kordzakhia E., Sorokovik I.N., Seredich I.N. Peculiarities of hemostasisin newborns from mothers with new coronavirus infection SARS-CoV-2 (COVID-19). Military Medicine. 2022;(2):39-50. (In Russ.) https://doi.org/10.51922/2074-5044.2022.2.39

Views: 13

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-5044 (Print)